|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Obesity Therapeutics: Understanding market dynamics (presentation) |
|
|
|
|
€ 4 556,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Avril 2007 |
Taille du document : |
21 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 52 pages | Août 2004 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,life sciences,hospital,...
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,mauritius,france,india |
| |
|
|
|
|
| 46 pages | Septembre 2000 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,private healthcare
|
| Research
focus: |
market size and estimates,market segmentation, |
| Geographic
focus: |
united kingdom,usa,japan,philippines,germany,... |
| |
|
|
|
|
| 78 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,united kingdom,australia |
| |
|
|
|
|
| 52 pages | Janvier 2007 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,healthcare informatics,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,canada,australia,china |
| |
|
|
|
|
| 84 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
healthcare,health care,dentists,life sciences,...
|
| Research
focus: |
demand analysis,competition analysis, |
| Geographic
focus: |
usa,mexico,india,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
The UK piling Market
40 pages | Mai 2002 |
This report will enable you to:Analyse the size of the UK market for piling between 1997 and 2006Quantify the size of the UK market for piling, 1997-2006, by technique: - bored - driven - embedded |
365,00 €
|
| |
| |
The CNS Outlook 2000
203 pages | Octobre 2000 |
The Central Nervous System (CNS) market has shown sustained growth in 1999 with the expansion continuing to be driven by several factors.A greater understanding of the neuropharmacological mechanisms |
955,00 €
|
| |
| |
Strategic Intelligence: The Top 12 Pharmaceutical Companies
158 pages | Novembre 2001 |
The pressure on the pharmaceutical company R&D has never been greater.
It is estimated that $100 billion worth of products will face patent expiry by 2005.
Of this, $37 billion represe |
1 021,89 €
|
| |
| |
Pharmaceutical Packaging: UK
90 pages | Avril 2000 |
· Analyse the changes in demand for pharmaceutical packaging in the UK, over the next 5 years
· Understand the main factors affecting demand
· Examine the struct |
1 249,31 €
|
| |
| |
The Drug Delivery Outlook 2001
176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery.
Subseque |
955,00 €
|
| |
| |
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs
119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike.
A great need exists for ph |
795,00 €
|
| |
| |
Pharmaceutical Pricing Strategies
121 pages | Juillet 1998 |
Which pricing strategies will enable your company to maximise profitability? As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to mainta |
795,00 €
|
| |
| |
European Pharmaceutical Industry
35 pages | Juillet 2002 |
The Pharmaceutical industry remains one of Europe’s best performing sectors (employment, R&D and trade surplus).
The world pharmaceutical market was worth an estimated € 392,640 million (at ex-fact |
600,00 €
|
| |
| |
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Obesity Therapeutics: Understanding market dynamics (presentation) |
|
|
Introduction
Obesity Therapeutics: Understanding Market Dynamics, a presentation given by Datamonitor at the Obesity Drug Development Summit in July 2006.
Scope
An overview of the obesity epidemic given by Datamonitor's Healthcare team. Lists of current obesity drugs and those in development.
Highlights
It is estimated that 44% of US adults and 29% of European adults are currently considered Dieters.
Reasons to Purchase
Understand the current state and growth rates of obesity. Assess the treatment options for obesity including drug types.
|
|
Introduction
Obesity Therapeutics: Understanding Market Dynamics, a presentation given by Datamonitor at the Obesity Drug Development Summit in July 2006.
Scope
An overview of the obesity epidemic given by Datamonitor's Healthcare team. Lists of current obesity drugs and those in development.
Highlights
It is estimated that 44% of US adults and 29% of European adults are currently considered Dieters.
Reasons to Purchase
Understand the current state and growth rates of obesity. Assess the treatment options for obesity including drug types.
|
|
|
PPLSEN
|
|
|
|
|
